SCHEMBL3760425

SCHEMBL3760425

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccc(NS(C)(=O)=O)cc3)c2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.41
PIK3CD O00329 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
MTOR P42345 9/20 0.41
JAK2 O60674 1/20 0.41
JAK3 P52333 1/20 0.41
BRD4 O60885 2/20 0.40
PIK3R1 P27986 2/20 0.38
USP2 O75604 2/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
MET P08581 1/20 0.36
TNIK Q9UKE5 1/20 0.35
PDE10A Q9Y233 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3761651 0.85 ALDH1A1 (0.48) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3766696 0.85 POLB (0.43) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3755564 0.84 PIK3CA (0.45) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3766002 0.84 PIK3CA (0.45) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3761675 0.83 ALDH1A1 (0.47) PIK3CAUSP2LMNAMAPT
SCHEMBL3760606 0.82 PRKDC (0.46) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3769513 0.82 GABRG2 (0.50) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3751853 0.82 PIK3CA (0.42) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3763668 0.81 PIK3CA (0.42) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3756222 0.79 BRD4 (0.44) PIK3CAPIK3CDPIK3CBPIK3CGBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885PIK3CD 9/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.